Evaxion A (EVAX) Enterprise Value (2019 - 2026)
Evaxion A (EVAX) posted Enterprise Value of -$18.4 million for Q1 2026, up 20.63% quarter-over-quarter from -$23.2 million in Q4 2025, and down 3.35% year-on-year from -$19.1 million in Q1 2025.
Evaxion A (EVAX) Enterprise Value (2019 - 2026) Analysis & Trends
Evaxion A (EVAX) has reported Enterprise Value for 8 consecutive years, with -$18.4 million the latest figure, recorded in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$18.4 million, down 3.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$18.4 million (down 3.35% YoY), and the FY2025 annual result was -$23.2 million, down 290.36% from the prior year.
- Enterprise Value was -$18.4 million for Q1 2026 at Evaxion A, up from -$23.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$11731.0 in Q1 2024 and troughed at -$31.4 million in Q1 2022.
- Average Enterprise Value over 5 years is -$13.3 million, with a median of -$11.9 million recorded in 2022.
- Year-over-year, Enterprise Value surged 99.89% in 2024 and slumped 152001.27% in 2025.
- Over 5 years, Enterprise Value stood at -$13.2 million in 2022, then surged by 57.65% to -$5.6 million in 2023, then dropped by 6.61% to -$6.0 million in 2024, then tumbled by 290.36% to -$23.2 million in 2025, then grew by 20.63% to -$18.4 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$18.4 million in Q1 2026, -$23.2 million in Q4 2025, and -$10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | -1.52 Bn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -2.77 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | -4.79 Bn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | -7.25 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | - |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | - |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | -3.01 Bn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -1.91 Bn |
| 10 | Evaxion A | 1.33 Bn | 1.33 Bn | - | -18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.44 Mn |
| Jun 30, 2025 | -14.75 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Dec 31, 2024 | -5.95 Mn |
| Jun 30, 2024 | -7.99 Mn |
| Mar 31, 2024 | -11,731.00 |
| Jun 30, 2023 | -7.12 Mn |
| Mar 31, 2023 | -10.24 Mn |
| Jun 30, 2022 | -25.25 Mn |
| Mar 31, 2022 | -31.41 Mn |
| Sep 30, 2021 | -11.94 Mn |
| Jun 30, 2021 | -18.80 Mn |
| Mar 31, 2021 | -26.96 Mn |
| Dec 31, 2020 | -5.83 Mn |
| Dec 31, 2019 | -9.56 Mn |